SCHEMBL2546341

SCHEMBL2546341

CNC(=O)/C(=N/OC)c1ccc(COc2cc(C)ccc2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 4/20 0.41
HTT P42858 3/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
POLB P06746 2/20 0.41
MAPT P10636 3/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 2/20 0.40
KDM4E B2RXH2 3/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ATM Q13315 1/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221378 0.86 RXRA (0.59) ALDH1A1SMN1; SMN2LMNAHTTRXRA
SCHEMBL8619481 0.86 RXRA (0.59) ALDH1A1SMN1; SMN2LMNAHTTRXRA
SCHEMBL29673995 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL22326129 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL54336 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL18420 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL31349879 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL2866788 0.80 HIF1A (0.49) ALDH1A1SMN1; SMN2LMNAHTTPOLB
SCHEMBL8622043 0.76 MRGPRX4 (0.49) ALDH1A1SMN1; SMN2LMNARXRARXRB
SCHEMBL8622039 0.76 MRGPRX4 (0.49) ALDH1A1SMN1; SMN2LMNARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044084-B2 Mixture comprising strobilurins and ethylene modulators BASF SE (DE) 2011-10-25 US disclosed
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides BASF AKTIENGESELLSCHAFT (DE) 2009-02-12 US disclosed
US-7307172-B2 7-amino triazolopyrimidines for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2007-12-11 US disclosed
US-20050261314-A1 7-Amino triazolopyrimidines for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261314-A1 7-Amino triazolopyrimidines for controlling harmful fungi POLR1C, TYR, TH ALDH1A1 1013/4885SMN1; SMN2 4569/4885LMNA 4179/4885
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides CBR3, CBR1, SNU13 ALDH1A1 1177/4885SMN1; SMN2 2440/4885LMNA 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.